On this episode of Let's Talk Medtech we speak with Anthony Fernando, president and CEO of Asensus Surgical, formerly known as Transenterix. Fernando opens up about the recent name change and the new philosophy of the company.

Omar Ford

April 21, 2021

1 Min Read
Courtesy of Asensus Surgical

TransEnterix has changed its name and has slightly altered its mission in surgical robotics. Now called Asensus Surgical, the company has a broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics. 

Let's Talk Medtech goes one-on-one with Asensus Surgical's President and CEO, Anthony Fernando to talk about the change and why the firm is so much more than a surgical robotics company.  Click here for the episode. 





About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like